Rebuttal to Drs. Reed and Harrand

摘要

Drs. Reed and Harrand suggest a watch-and-wait policy as an alternative to treating all patients with high-intermediate risk (HER) factors after surgery with vaginal brachytherapy. Obviously, gsros and cons of both strategies should be discussed. However, it should be realized that the high-salvage rates after recurrence of 80%, as cited by Reed, have only been obtained in patients with relatively small isolated vaginal recurrences, whereas salvage rates are significantly lower for patients presenting with a nodal or combined local and nodal pelvic failure